MetLife, Inc. (NYSE:MET) Receives $88.62 Consensus Price Target from Analysts

MetLife, Inc. (NYSE:METGet Free Report) has been given an average rating of “Buy” by the thirteen ratings firms that are currently covering the firm, MarketBeat.com reports. Thirteen equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $88.62.

MET has been the topic of several recent research reports. Morgan Stanley decreased their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. Wells Fargo & Company boosted their target price on MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Barclays cut their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Finally, Piper Sandler raised their price target on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd.

View Our Latest Analysis on MetLife

MetLife Price Performance

MetLife stock opened at $80.33 on Monday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market cap of $55.62 billion, a price-to-earnings ratio of 16.29, a P/E/G ratio of 0.78 and a beta of 1.06. The business’s 50-day simple moving average is $83.78 and its 200 day simple moving average is $77.20. MetLife has a 12-month low of $64.61 and a 12-month high of $89.05.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be given a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.71%. The ex-dividend date is Tuesday, November 5th. MetLife’s payout ratio is presently 43.95%.

Institutional Investors Weigh In On MetLife

A number of large investors have recently modified their holdings of MET. MeadowBrook Investment Advisors LLC grew its stake in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. grew its position in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC increased its holdings in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new position in MetLife in the third quarter valued at about $30,000. Finally, Fortitude Family Office LLC boosted its stake in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 266 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Company Profile

(Get Free Report

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.